Most sold healthcare stocks in Q4 2024
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q4 2024 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include ACADIA HEALTHCARE CO INC (ACHC), STANDARD BIOTOOLS INC (LAB), DOXIMITY INC-CLASS A (DOCS), BUTTERFLY NETWORK INC (BFLY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ACHC | ACADIA HEALTHCARE CO INC | -6,017,498 | -$381.6M | 0 | 0 | 1 | 4 | 1 |
| LAB | STANDARD BIOTOOLS INC | -5,827,076 | -$22.4M | 0 | 0 | 1 | 1 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -4,081,873 | -$124.2M | 3 | 1 | 3 | 0 | 7 |
| BFLY | BUTTERFLY NETWORK INC | -3,744,103 | $2.9M | 1 | 0 | 3 | 1 | 4 |
| PFE | PFIZER INC | -3,651,136 | -$164.9M | 7 | 8 | 14 | 1 | 31 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -3,404,900 | $13.9M | 1 | 2 | 5 | 0 | 9 |
| ME | 23ANDME HOLDING CO -CLASS A | -3,138,861 | -$1.1M | 0 | 0 | 0 | 2 | 0 |
| OPCH | OPTION CARE HEALTH INC | -2,507,593 | -$81.2M | 0 | 1 | 1 | 3 | 2 |
| QSI | QUANTUM-SI INC | -2,490,303 | $14.9M | 1 | 1 | 1 | 0 | 3 |
| NVRO | NEVRO CORP | -2,459,566 | -$14.3M | 0 | 0 | 1 | 1 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | -2,409,663 | -$33.9M | 0 | 1 | 0 | 1 | 1 |
| CARA | CARA THERAPEUTICS INC | -2,221,974 | -$684.4K | 0 | 0 | 0 | 2 | 0 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -2,116,675 | $23.9M | 0 | 1 | 1 | 0 | 3 |
| FTRE | FORTREA HOLDINGS INC | -1,982,399 | $5.7M | 1 | 1 | 0 | 2 | 2 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | -1,969,141 | -$65.6M | 0 | 0 | 0 | 2 | 0 |
| ZLAB | ZAI LAB LTD-ADR | -1,850,437 | -$44.3M | 0 | 1 | 0 | 1 | 3 |
| SGMO | SANGAMO THERAPEUTICS INC | -1,767,900 | -$1.1M | 0 | 0 | 1 | 0 | 1 |
| CNC | CENTENE CORP | -1,650,968 | -$144.9M | 3 | 3 | 2 | 3 | 9 |
| OSCR | OSCAR HEALTH INC - CLASS A | -1,557,650 | -$126.8M | 2 | 3 | 4 | 0 | 9 |
| BLUE | BLUEBIRD BIO INC | -1,451,674 | -$754.1K | 0 | 0 | 0 | 4 | 0 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -1,413,300 | -$332.7K | 0 | 0 | 1 | 0 | 3 |
| KZR | KEZAR LIFE SCIENCES INC | -1,297,074 | -$1.0M | 0 | 0 | 0 | 1 | 0 |
| UNH | UNITEDHEALTH GROUP INC | -1,163,039 | -$1.9B | 12 | 21 | 12 | 1 | 51 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -1,026,732 | -$451.8M | 5 | 5 | 5 | 0 | 18 |
| IMVT | IMMUNOVANT INC | -1,021,712 | -$34.7M | 0 | 0 | 2 | 0 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | -1,003,840 | -$53.0M | 3 | 5 | 5 | 0 | 17 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -932,644 | $6.2M | 0 | 0 | 1 | 0 | 2 |
| NRIX | NURIX THERAPEUTICS INC | -932,472 | -$26.5M | 0 | 0 | 1 | 1 | 1 |
| ABT | ABBOTT LABORATORIES | -914,984 | -$122.3M | 6 | 8 | 7 | 0 | 28 |
| VKTX | VIKING THERAPEUTICS INC | -903,717 | -$57.5M | 0 | 1 | 0 | 3 | 1 |
| SNY | SANOFI-ADR | -902,527 | -$769.0M | 2 | 5 | 2 | 1 | 10 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -886,211 | -$16.2M | 2 | 1 | 2 | 0 | 5 |
| ACCD | ACCOLADE INC | -882,656 | -$5.5M | 1 | 0 | 2 | 0 | 3 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -834,807 | -$174.8M | 4 | 7 | 4 | 1 | 15 |
| HLN | HALEON PLC-ADR | -826,812 | -$197.9M | 1 | 2 | 4 | 0 | 9 |
| CAH | CARDINAL HEALTH INC | -826,527 | -$74.9M | 0 | 4 | 3 | 3 | 8 |
| HRTX | HERON THERAPEUTICS INC | -822,898 | -$2.2M | 0 | 0 | 1 | 1 | 1 |
| MOH | MOLINA HEALTHCARE INC | -795,020 | -$332.2M | 1 | 2 | 5 | 1 | 8 |
| OGN | ORGANON & CO | -740,679 | -$41.8M | 2 | 0 | 5 | 2 | 9 |
| GLYC | GLYCOMIMETICS INC | -739,947 | -$121.8K | 0 | 0 | 1 | 0 | 1 |
| VCYT | VERACYTE INC | -703,850 | $2.9M | 0 | 3 | 1 | 0 | 4 |
| ALHC | ALIGNMENT HEALTHCARE INC | -655,718 | -$11.4M | 0 | 1 | 1 | 0 | 2 |
| BAYRY | BAYER AG-SPONSORED ADR | -653,317 | -$21.7M | 0 | 0 | 1 | 0 | 1 |
| CTLT | CATALENT INC | -652,675 | -$39.5M | 0 | 0 | 0 | 4 | 0 |
| ELAN | ELANCO ANIMAL HEALTH INC | -642,337 | -$224.5M | 1 | 0 | 4 | 0 | 5 |
| NVAX | NOVAVAX INC | -635,890 | -$15.0M | 1 | 1 | 2 | 0 | 6 |
| CHRS | COHERUS BIOSCIENCES INC | -629,537 | -$461.3K | 2 | 0 | 1 | 1 | 3 |
| PSTX | POSEIDA THERAPEUTICS INC | -626,403 | $832.8K | 0 | 0 | 1 | 0 | 2 |
| RPTX | REPARE THERAPEUTICS INC | -615,980 | -$7.1M | 0 | 0 | 2 | 0 | 2 |
| CRBU | CARIBOU BIOSCIENCES INC | -594,200 | -$1.2M | 0 | 0 | 0 | 1 | 1 |